Abstract Deficiency of Fas-mediated apoptosis is one of the mechanisms involved in the immune evasion by tumors. Thus, it might be a practical approach for cancer treatment that Fas-mediated apoptosis in tumor cells is modified by drugs. In the course of screening, we have isolated two new naphthoquinones, f13102A and B, from the culture broth of fungus strain F-13102. Coumpound f13102A sensitizes Fas-resistant human lung adenocarcinoma A549 cells to apoptosis.
Fas (CD95/APO-1), a member of the TNF receptor family, is a death receptor that induces apoptosis upon ligation with its intrinsic ligand, Fas ligand (FasL). Fas-mediated apoptosis plays important roles in the immune system, including an elimination of tumor cells by cytotoxic T lymphocytes [1ϳ4] . Fas expression is in fact shown as a significant prognostic factor in the human malignancies [5ϳ7] . In addition, we have recently demonstrated that the Fas-mediated apoptosis of tumor cells and host immune defense are involved in an antitumor effect of drugs [8] . Thus, it might be a practical approach for cancer treatment that Fas-mediated apoptosis in tumor cells is modified by drugs. In the course of screening, we have found that a culture broth of fungus strain F-13102 sensitizes Fasresistant human lung adenocarcinoma A549 cells [9] to apoptosis. We isolated two new compounds, f13102A (1) and B (2), from the culture broth. In this paper, we describe the fermentation, isolation, physico-chemical properties, structure elucidation, and biological activities of 1 and 2.
Fungus strain F-13102 was isolated from a soil sample collected in Hahajima, Ogasawara Islands, Tokyo Prefecture, Japan. A slant culture of the strain F-13102 was inoculated into 100 ml of a seed culture medium containing glucose 1%, potato starch 2%, soybean meal 2%, KH 2 PO 4 0.1%, MgSO 4 · 7H 2 O 0.05%, and five glass beads, and cultured at 25°C for 3 days on a rotary shaker (225 rpm). For production of 1 and 2, the seed culture (5 ml) was inoculated into a 500-ml flask containing 100 ml of a culture medium containing glycerin 5%, potato extract 25%, malt extract 0.5%, and yeast extract 0.5%, and cultured at 25°C for 4 days on a rotary shaker (225 rpm).
The cultured broth (10.0 liter) was extracted with an equal volume of EtOAc and filtered. The organic layer was concentrated to give a brown oily material (7.04 g). The material was dissolved in a small volume of 90% MeOH and washed with n-hexane. The residue was concentrated in vacuo to give a brown oily material (1.33 g). The oily material was applied on a silica gel column and the active substances were eluted with CHCl 3 -MeOH (100 : 1). The active fractions were collected and concentrated to give a yellow oil (212.5 mg). The yellow oil was subjected to reversed phase HPLC (Inertsil ODS-3, GL Science) with 40% CH 3 CN. The active fractions containing 1 were J. Antibiot. 58 (9) The UV absorpotion maxima of 1 and 2 are closely resemble to that of misakimycin [10] indicating the presence of naphthoquinone moieties in 1 and 2. The HRESI-MS spectrum of 1 led to the molecular formula C 13 H 12 O 5 .
The 13 C NMR, DEPT, and HMQC spectra of 1 revealed the presence of thirteen carbon signals consisting of two methyls, one methylene, two methines, and eight quaternary carbons. The 1 H NMR spectrum of 1 indicated a chelated OH group at d H 12.6. The aromatic region of the spectrum indicated two singlets at d H 6.1 and 7.8 suggesting the presence of a tetra-substituted naphthoquinone. The aliphatic region of the spectrum indicated singlets at d H 2.2, 3.9 and 4.8 due to naphthoquinone-bound methyl, methoxy and hydroxymethyl protons, respectively. The conectivity of these functional groups and naphthoquinone ring was elucidated by HMBC experiments as shown in Fig. 1 . The observed correlations were as follows; from 2-OCH 3 to C-2, from 3-H to C-1, C-2, and C-4a, from 5-OH to C-4a, C-5, and C-6, from 6-CH 3 to C-5, C-6, and C-7, from 8-H to C-1, C-4a, C-5, C-7Ј, and from 7Ј-H 2 to C-8. Thus, the structure of 1 was concluded as 5-hydroxy-7-hydroxymethyl-2-methoxy-6-methyl-1,4-naphthoquinone.
The molecular formula of 2 was determined to be C 13 H 12 O 6 based on the HRESI-MS. The 1 H and 13 C NMR spectra of 1 and 2 were similar to each other. In DEPT spectra, one methyl carbon in 1 was replaced to one methylene carbon in 2. Further analysis confirmed that 6-methyl in 1 was replaced to hydroxymethyl in 2 as shown in Fig. 1 . The observed correlations in 2 were as follows; from 2-OCH 3 to C-2, from 3-H to C-1, C-2, C-4, and C-4a, from 8-H to C-1, C-4a, C-6, and C-7Ј, from 7Ј-H 2 to C-6, C-7, and C-8, and from 6Ј-H 2 to C-5, C-6, and C-7. Thus, the structure of 2 was concluded as 6,7-dihydroxymethyl-5-hydroxy-2-methoxy-1,4-naphthoquinone. The 1 H and 13 C NMR assignments of 1 and 2 are summarized in Table 1 .
The compound-induced sensitization to Fas-mediated apoptosis was assessed. A549 cells were seeded in 96 well culture plates and CH-11, an anti-Fas agonistic antibody [11] , (100 ng/ml), and cycloheximide (1 m g/ml) were added. After 48 hours, the viable cell number was measured by MTT assay. As shown in Fig. 2 , compound 1 dose-dependently sensitized cells to Fasmediated apoptosis (IC 50 0.1 mg/ml). In the reference wells (cycloheximide only), antiproliferative effect of 1 was 10 times weaker (IC 50 1.0 mg/ml) than that in the presence of CH-11. Compound 1 did not inhibit incorporation of naphthoquinone neither showed the selective effect. Therefore, compound 1 is considered to have a structurally unique activity. These compounds showed weak antimicrobial activity. The MIC values were as follows: compound 1: 4 m g/ml against Staphylococcus aureus FDA209P, 16 mg/ml against S. aureus MS16526 (MRSA), 4 m g/ml against Bacillus subtilis PCI219, 16 m g/ml against Escherichia coli NIHJ, 4 m g/ml against E. coli BE112i; compound 2: 4 m g/ml against S. aureus FDA209P, 8 m g/ml against S. aureus MS16526 (MRSA), 8 m g/ml against B. subtilis PCI219, 8 m g/ml against E. coli NIHJ, 1 m g/ml against E. coli BE1121. 
